Axon Enterprise, Inc $AXON Shares Sold by Brookstone Capital Management

Brookstone Capital Management cut its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 7.8% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 791 shares of the biotechnology company’s stock after selling 67 shares during the quarter. Brookstone Capital Management’s holdings in Axon Enterprise were worth $655,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of AXON. TCTC Holdings LLC lifted its holdings in shares of Axon Enterprise by 75.0% during the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock worth $29,000 after purchasing an additional 24 shares during the period. Bartlett & CO. Wealth Management LLC lifted its holdings in Axon Enterprise by 132.0% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock valued at $31,000 after acquiring an additional 33 shares during the period. Banque Transatlantique SA acquired a new stake in Axon Enterprise in the first quarter valued at $31,000. Catalyst Capital Advisors LLC acquired a new stake in Axon Enterprise in the first quarter valued at $32,000. Finally, Flaharty Asset Management LLC acquired a new stake in Axon Enterprise in the first quarter valued at $33,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the company. Raymond James Financial reissued an “outperform” rating and issued a $855.00 target price (up previously from $645.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Piper Sandler assumed coverage on Axon Enterprise in a research note on Tuesday, September 23rd. They set an “overweight” rating and a $893.00 price target for the company. Needham & Company LLC reaffirmed a “buy” rating and set a $870.00 price target on shares of Axon Enterprise in a research note on Wednesday, September 24th. UBS Group reaffirmed a “neutral” rating and set a $840.00 price target (up previously from $820.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Finally, JPMorgan Chase & Co. lifted their price target on Axon Enterprise from $730.00 to $850.00 and gave the stock an “overweight” rating in a research note on Thursday, July 17th. Fourteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $841.64.

Insider Activity

In related news, President Joshua Isner sold 15,919 shares of Axon Enterprise stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $746.26, for a total transaction of $11,879,712.94. Following the completion of the sale, the president owned 238,379 shares in the company, valued at approximately $177,892,712.54. This trade represents a 6.26% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CAO Jennifer H. Mak sold 77 shares of Axon Enterprise stock in a transaction dated Monday, September 15th. The stock was sold at an average price of $760.00, for a total value of $58,520.00. Following the sale, the chief accounting officer owned 15,003 shares of the company’s stock, valued at approximately $11,402,280. This represents a 0.51% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 59,932 shares of company stock worth $45,115,616 in the last quarter. Corporate insiders own 5.70% of the company’s stock.

Axon Enterprise Trading Up 2.7%

Axon Enterprise stock opened at $735.95 on Monday. The stock has a market cap of $57.77 billion, a PE ratio of 181.72, a P/E/G ratio of 28.58 and a beta of 1.41. The stock has a 50-day moving average price of $733.17 and a 200 day moving average price of $726.44. Axon Enterprise, Inc has a 52 week low of $422.38 and a 52 week high of $885.91. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, topping analysts’ consensus estimates of $1.54 by $0.58. The firm had revenue of $668.54 million during the quarter, compared to analysts’ expectations of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The firm’s quarterly revenue was up 32.6% compared to the same quarter last year. During the same quarter last year, the business posted $1.20 EPS. Axon Enterprise has set its FY 2025 guidance at EPS. Equities research analysts predict that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.